Development of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase autoantibodies using a non‐radioactive biotinylated recombinant protein

Documenti analoghi

• Myositis‐specific/associated autoantibodies as diagnostic keys and disease drivers
  di: Satoshi Yamashita
  Pubblicazione: (2024)
• Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications
  di: Makoto Nakashima, et al.
  Pubblicazione: (2025)
• Effect of Disease‐Modifying Treatments in Japanese Patients With Multiple Sclerosis During the Coronavirus Disease 2019 Pandemic
  di: Taisuke Ogawa, et al.
  Pubblicazione: (2025)
• Clinical value of the Japanese version of patient‐reported multiple sclerosis neuropsychological screening questionnaire
  di: Atsuya Muryoi, et al.
  Pubblicazione: (2025)
• Comparison of the sensitivity of anti‐acetylcholine receptor enzyme‐linked immunosorbent assay and radioimmunoassay in different treatment periods
  di: Naoki Kawaguchi, et al.
  Pubblicazione: (2025)